Prognostic value of red cell distribution width in patients with sarcoidosis

Clinical Respiratory Journal

Volumn 9, Issue 1, 2015, Pages 34-38

  Ozsu, Savas ^a   Ozcelik, Neslihan ^a   Oztuna, Funda ^a   Ozlu, Tevfik ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Prognosis; Red cell distribution width; Sarcoidosis

Indexed keywords

ADULT; ARTICLE; BLOOD CELL COUNT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; ERYTHROCYTE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; LUNG BIOPSY; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MIDDLE AGED; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RED CELL DISTRIBUTION WIDTH; REMISSION; RETROSPECTIVE STUDY; BLOOD; DISEASE COURSE; FEMALE; MALE; MEAN CORPUSCULAR VOLUME; SARCOIDOSIS;

ADULT; DISEASE PROGRESSION; ERYTHROCYTE INDICES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SARCOIDOSIS;

EID: 84923228555     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/crj.12101     Document Type: Article

References (18)

1. Kiter G, Müsellim B, Cetinkaya E, etal.; Sarcoidosis Working Group of Turkish Thoracic Society. Clinical presentations and diagnostic work-up in sarcoidosis: a series of Turkish cases (clinics and diagnosis of sarcoidosis). Tuberk Toraks. 2011;59(3): 248-258.
2. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357(21): 2153-2165.
3. Schweiger DJ. Red cell distribution width in sickle cell anemia. Am J Med Technol. 1981;47(4): 231-233.
4. Bazick HS, Chang D, Mahadevappa K, Gibbons FK, Christopher KB. Red cell distribution width and all-cause mortality in critically ill patients. Crit Care Med. 2011;39(8): 1913-1921.
5. Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med. 2009;133(4): 628-632.
6. Balta S, Aydogan M, Kurt O, Karaman M, Demirkol S, Akgul EO. Red cell distribution width as a novel, simple, inexpensive predictor of mortality in patients with chronic heart failure. Int J Cardiol. 2013;168(3): 3049-3050.
7. Ozsu S, Abul Y, Gunaydin S, Orem A, Ozlu T. Prognostic value of red cell distribution width in patients with pulmonary embolism. Clin Appl Thromb Hemost. 2014. doi: 10.1177/1076029612464901.
8. Ozsu S, Abul Y, Gulsoy A, Bulbul Y, Yaman S, Ozlu T. Red cell distribution width in patients with obstructive sleep apnea syndrome. Lung. 2012;190(3): 319-326.
9. Nathan SD, Reffett T, Brown AW, Fischer CP, Shlobin OA, Ahmad S, Weir N, Sheridan MJ. The red cell distribution width as a prognostic indicator in idiopathic pulmonary fibrosis. Chest. 2013;143(6): 1692-1698.
10. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160: 736-755.
11. Costabel U. Sensitivity and specificity of BAL findings in sarcoidosis. Sarcoidosis. 1992;9(1): 211-214.
12. Scadding JG. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation. Br Med J. 1961;2(5261): 1165-1172.
13. Hampole CV, Mehrotra AK, Thenappan T, Gomberg-Maitland M, Shah SJ. Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension. Am J Cardiol. 2009;104(6): 868-872.
14. Wang F, Pan W, Pan S, Ge J, Wang S, Chen M. Red cell distribution width as a novel predictor of mortality in ICU patients. Ann Med. 2011;43(1): 40-46.
15. Grant BJ, Kudalkar DP, Muti P, McCann SE, Trevisan M, Freudenheim JL, Schünemann HJ. Relation between lung function and RBC distribution width in a population-based study. Chest. 2003;124(2): 494-500.
16. Rothkrantz-Kos S, van Dieijen-Visser MP, Mulder PG, Drent M. Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis. Clin Chem. 2003;49(9): 1510-1517.
17. DeRemee RA, Rohrbach MS. Serum angiotensin-converting enzyme activity in evaluating the clinical course of sarcoidosis. Ann Intern Med. 1980;92(3): 361-365.
18. Pietinalho A, Ohmichi M, Löfroos AB, Hiraga Y, Selroos O. The prognosis of pulmonary sarcoidosis in Finland and Hokkaido, Japan. A comparative five-year study of biopsy-proven cases. Sarcoidosis Vasc Diffuse Lung Dis. 2000;17(2): 158-166.